Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024

BUY
$0.53 - $1.14 $282 - $607
533 Added 108.78%
1,023 $0
Q3 2023

Nov 01, 2023

BUY
$0.84 - $1.43 $411 - $700
490 New
490 $0
Q1 2023

Apr 27, 2023

SELL
$0.91 - $1.69 $11,960 - $22,211
-13,143 Reduced 89.05%
1,616 $1,000
Q4 2022

Feb 02, 2023

SELL
$1.09 - $2.04 $289 - $542
-266 Reduced 1.77%
14,759 $18,000
Q3 2022

Nov 04, 2022

SELL
$1.55 - $3.01 $31,415 - $61,006
-20,268 Reduced 57.43%
15,025 $24,000
Q2 2022

Aug 03, 2022

BUY
$1.39 - $3.12 $30,873 - $69,298
22,211 Added 169.78%
35,293 $69,000
Q1 2022

May 02, 2022

BUY
$2.6 - $4.17 $23,530 - $37,738
9,050 Added 224.45%
13,082 $39,000
Q4 2021

Feb 23, 2022

SELL
$3.64 - $7.78 $13,231 - $28,280
-3,635 Reduced 47.41%
4,032 $14,000
Q3 2021

Oct 28, 2021

SELL
$6.01 - $8.71 $1,027 - $1,489
-171 Reduced 2.18%
7,667 $57,000
Q2 2021

Aug 12, 2021

BUY
$6.02 - $9.64 $6,080 - $9,736
1,010 Added 14.79%
7,838 $56,000
Q1 2021

Apr 26, 2021

BUY
$9.17 - $14.8 $51,883 - $83,738
5,658 Added 483.59%
6,828 $64,000
Q4 2020

Feb 02, 2021

SELL
$8.92 - $13.29 $90,448 - $134,760
-10,140 Reduced 89.66%
1,170 $13,000
Q3 2020

Oct 14, 2020

BUY
$9.94 - $16.59 $80,792 - $134,843
8,128 Added 255.44%
11,310 $121,000
Q2 2020

Jul 13, 2020

BUY
$12.07 - $19.34 $6,879 - $11,023
570 Added 21.82%
3,182 $0
Q1 2020

Apr 29, 2020

BUY
$12.5 - $22.04 $19,150 - $33,765
1,532 Added 141.85%
2,612 $40,000
Q4 2019

Feb 05, 2020

BUY
$11.42 - $22.19 $11,636 - $22,611
1,019 Added 1670.49%
1,080 $22,000
Q3 2019

Oct 15, 2019

BUY
$14.74 - $22.28 $899 - $1,359
61 New
61 $0

Others Institutions Holding FIXX

About Homology Medicines, Inc.


  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.